The Cosmetology Market is estimated to be valued at US$ 118.62 Bn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cosmetology deals with the beautification, grooming and overall enhancement of one’s appearance through the use of various makeup and skincare products. The cosmetology market offers a wide range of products like skin and hair care products, makeup, perfumes and deodorants. These products enhance facial qualities, protect and moisturize the skin from damaging UV rays, nourish hair follicles and lend an aesthetic appeal. Rising consciousness towards one’s appearance has boosted the need for cosmetology products globally.
Market key trends:
The global cosmetology market is witnessing high growth owing to rising e-commerce retail platform trends. Online sales of beauty and personal care products have witnessed a substantial increase in the past few years with growing number of people shopping through their mobile phones and internet connectivity. E-commerce giants are investing heavily in building their own beauty products portfolio and partnering with existing brands to strengthen their online presence. This has boosted the online sale of cosmetic products globally. Various players are adopting online marketing strategies and improving their e-websites or Apps for providing seamless shopping experience to online customers. Growing e-commerce trends is a major factor fuelling the demand for cosmetology products.
Porter’s Analysis
Threat of new entrants: New entrants face high capital requirements for R&D, branding and distribution.
Bargaining power of buyers: Buyers have high bargaining power due to large number of existing brands.
Bargaining power of suppliers: Suppliers have moderate power due to differentiation in raw materials.
Threat of new substitutes: Threat is moderate as new products require expensive certification.
Competitive rivalry: Intense competition among existing major players.
SWOT Analysis
Strengths: Strong brand image and loyalty, global expansion.
Weaknesses: High capital expenditure, price wars.
Opportunities: Emerging markets, social media marketing.
Threats: Stringent regulations, counterfeiting.
Key Takeaways
The Global Cosmetology Market Size is expected to witness high growth, exhibiting CAGR of 9.5% over the forecast period, due to increasing disposable income in developing countries. Asia Pacific dominates the global market, with China being the fastest growing market. The region is expected to grow at a CAGR of around 11% till 2030 owing to large population, growing middle class and their rising disposable income.
Regional analysis fastest growing and dominating region. The Asia Pacific region dominates the global cosmetology market and is expected to grow at the fastest pace during the forecast period. Countries such as China, India, Japan, and South Korea are major consumers of cosmetic products in the region. The Asia Pacific cosmetology market is estimated to reach around US$ 200 Bn by 2030, expanding at a CAGR of 11% from 2023-2030.
Key players related content comprises Key players operating in the cosmetology market are L'Oréal, Estée Lauder Companies Inc., Coty Inc., and Shiseido Company, Limited.
For More Insights, Read: https://www.newswirestats.com/cosmetology-market-demand-growth-and-regional-outlook-by-2030/
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
